Clinical Trials · NCT02217566
Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Janssen Research & Development, LLC
- Enrollment
- 46
- Start date
- Sep 2014
- Locations
- 4 sites, Brazil
- Primary endpoint
- Time to Prostate-specific Antigen (PSA) Progression